SIRPA and neoplasm: While the focus concerning immune checkpoint inhibition during the last years was largely on the adaptive part of the immune system, recent work has shed light on an innate immune checkpoint, involving the interaction between CD47 on tumor cells and signal regulatory protein alpha (SIRPα) on phagocytes (5).